What it is
A peptide preparation derived from enzymatic hydrolysis of porcine brain tissue, containing a defined mixture of low-molecular-weight peptides and free amino acids. Supplied as a sterile solution.
How it works
Proposed in preclinical and clinical studies to exert neurotrophic effects mimicking endogenous neurotrophic factors, supporting neuronal survival and synaptic plasticity.
Where it's used
Approved in several countries including Russia, China, Mexico, and parts of Europe for stroke, dementia, and traumatic brain injury. Not approved in the US.
Regulatory status
Not FDA-approved; not marketed in the US.
Reconstitution
Supplied as a pre-mixed sterile solution; no reconstitution required.
Tracking it
Cerebrolysin is injectable, so two things matter in a log: when you dosed and where. Rotating sites and writing both down prevents the classic “did I already pin the left side?” problem.
Source
Public reference
Last reviewed 2026-06-11